Cargando…
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
BACKGROUND: Ovarian carcinoma is the most lethal gynecological malignancy due to early dissemination and acquired resistance to platinum-based chemotherapy. Reliable markers that are independent and complementary to clinical parameters are needed to improve the management of patients with this disea...
Autores principales: | Le Page, Cécile, Rahimi, Kurosh, Köbel, Martin, Tonin, Patricia N., Meunier, Liliane, Portelance, Lise, Bernard, Monique, Nelson, Brad H., Bernardini, Marcus Q., Bartlett, John M. S., Bachvarov, Dimcho, Gotlieb, Walter H., Gilks, Blake, McAlpine, Jessica N., Nachtigal, Mark W., Piché, Alain, Watson, Peter H., Vanderhyden, Barbara, Huntsman, David G., Provencher, Diane M., Mes-Masson, Anne-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872529/ https://www.ncbi.nlm.nih.gov/pubmed/29587661 http://dx.doi.org/10.1186/s12885-018-4242-8 |
Ejemplares similares
-
A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
por: Le Page, Cécile, et al.
Publicado: (2019) -
Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease
por: Fleury, Hubert, et al.
Publicado: (2015) -
Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors
por: Ouellet, Véronique, et al.
Publicado: (2008) -
Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids
por: L'Espérance, Sylvain, et al.
Publicado: (2008) -
Cumulative defects in DNA repair pathways drive the PARP inhibitor response in high-grade serous epithelial ovarian cancer cell lines
por: Fleury, Hubert, et al.
Publicado: (2016)